Ep. 65 Should women of reproductive age take GLP-1s?

In this week's episode I discuss how GLP-1 medications like Ozempic, Wegovy, and similar weight-loss drugs are being used at unprecedented rates — especially by women of reproductive age. I share why this trend deeply concerns me, and why I believe these medications pose serious, largely unknown risks for future fertility, pregnancy outcomes, and long-term generational health.

This conversation has been building for months, fueled by client stories, cultural normalization of GLP-1s, influencer misinformation, and growing reports of severe side effects and lawsuits. It’s not about judgment — it’s about history, responsibility, and informed decision-making.

In This Episode, We Cover:

• Why FDA approval does not equal long-term safety

• The rise of GLP-1 use in women who want children someday

• Historical drug disasters (Vioxx, DES, Thalidomide) and what they teach us

• Emerging lawsuits and serious side effects linked to GLP-1 medications

• Nutrient depletion, gut health, and the role of the maternal microbiome

• Why appetite suppression ≠ true metabolic or reproductive health

• The risks of using GLP-1s before pregnancy — even if you stop once pregnant

• Why stopping breastfeeding to lose weight with these drugs is especially concerning

My Core Belief

Women deserve support that helps them get healthy, nourished, and hormonally resilient — not just thinner.

If this episode resonated, I’d love to hear from you. Come connect with me on Instagram @stefanieadlerwellness, and please share this episode with anyone navigating weight loss, fertility, or pregnancy decisions.

⭐️ Don’t forget to rate and review the show — it helps this message reach more women who need it.

If you’re ready to pursue health and weight loss the old-school way, book a call to learn more about working with me and my team! Click here to book a call.